Laser trabeculoplasty suitable for all open-angle glaucoma patientsProstaglandin-based topical therapy has been the ‘go-to treatment’ for open-angle glaucoma for decades. In contrast, laser trabeculoplasty has conventionally remained reserved for patients unresponsive or unable to adhere to medication-based therapy.
Laser system offers multiple treatments in single deviceNew laser technology in a single device offers multiple treatment platforms, including SLT for glaucoma, laser vitreolysis for floaters, capsulotomy, and iridotomy.
Know your glaucoma surgery for better comanagement
Know your glaucoma surgery for better comanagementTreating and managing chronic glaucoma can be rewarding as an optometrist. The frequency of office visits to monitor this chronic disease provides ODs an opportunity to develop a close relationship with their patients while providing medical eye care.
Better alternatives to standalone prostaglandin analog therapyPhysicians have the option of various adjunctive therapy when prostaglandin analog therapy alone is not sufficiently potent to lower IOP, i.e., they can add one agent, a fixed-combination therapy, or perform selective laser trabeculoplasty (SLT).
How to avoid bubble formation during SLTThe adjustment of treatment parameters may be an effective technique for surgeons to avoid bubble formation during selective laser trabeculoplasty.
Ellex launches canaloplasty e-bookEllex Medical Lasers Ltd. has released a comprehensive e-book—“It’s All About Outflow”—describing the role of canaloplasty in clinical practice.
Quantel’s Optimus Fusion receives FDA 501(k) clearanceThe U.S. Food and Drug Administration (FDA) has granted 501(k) clearance to Quantel Medical’s Optimus Fusion integrated laser platform.
SLT effective part of glaucoma care strategy in developing countriesSelective laser trabeculoplasty provided a majority of Afro-Caribbean patients with a mean IOP reduction of 40% with no need for medical therapy.
SLT without gonioscopy lens successfulSelective laser trabeculoplasty (SLT) without the use of a gonioscopy lens was performed successfully and still decreased IOP over 6 months, said Michael Belkin, MD.
Maximum medical therapy in glaucomaA few months ago, I began to see what may be a little more progression on her OCT studies. I’m fairly confident that we’re in a good place right now as far as compliance is concerned, and I’m entering a crossroads with her regarding possibly adding therapy vs. getting a consult for a laser procedure, such as selective laser trabeculoplasty (SLT), vs. getting a cataract consult.